199 related articles for article (PubMed ID: 27821086)
1. Antineoplastic treatment effect on bone mineral density in Mexican breast cancer patients.
Monroy-Cisneros K; Esparza-Romero J; Valencia ME; Guevara-Torres AG; Méndez-Estrada RO; Anduro-Corona I; Astiazarán-García H
BMC Cancer; 2016 Nov; 16(1):860. PubMed ID: 27821086
[TBL] [Abstract][Full Text] [Related]
2. Low bone mineral density is associated with breast cancer in postmenopausal women: a case-control study.
Ferreira Poloni P; Vespoli HL; Almeida-Filho BS; Bueloni-Dias F; Nahas-Neto J; Nahas EAP
Climacteric; 2017 Oct; 20(5):491-497. PubMed ID: 28569124
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy.
Gnant M; Mlineritsch B; Luschin-Ebengreuth G; Kainberger F; Kässmann H; Piswanger-Sölkner JC; Seifert M; Ploner F; Menzel C; Dubsky P; Fitzal F; Bjelic-Radisic V; Steger G; Greil R; Marth C; Kubista E; Samonigg H; Wohlmuth P; Mittlböck M; Jakesz R;
Lancet Oncol; 2008 Sep; 9(9):840-9. PubMed ID: 18718815
[TBL] [Abstract][Full Text] [Related]
4. Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification.
Grampp S; Genant HK; Mathur A; Lang P; Jergas M; Takada M; Glüer CC; Lu Y; Chavez M
J Bone Miner Res; 1997 May; 12(5):697-711. PubMed ID: 9144335
[TBL] [Abstract][Full Text] [Related]
5. Effects of menopause on bone mineral density in women with endemic fluorosis.
Yildiz M; Oral B
Clin Nucl Med; 2003 Apr; 28(4):308-11. PubMed ID: 12642710
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF).
Fogelman I; Blake GM; Blamey R; Palmer M; Sauerbrei W; Schumacher M; Serin D; Stewart A; Wilpshaar W
Osteoporos Int; 2003 Dec; 14(12):1001-6. PubMed ID: 14530912
[TBL] [Abstract][Full Text] [Related]
7. Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients.
Saarto T; Blomqvist C; Välimäki M; Mäkelä P; Sarna S; Elomaa I
J Clin Oncol; 1997 Apr; 15(4):1341-7. PubMed ID: 9193325
[TBL] [Abstract][Full Text] [Related]
8. Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17.
Perez EA; Josse RG; Pritchard KI; Ingle JN; Martino S; Findlay BP; Shenkier TN; Tozer RG; Palmer MJ; Shepherd LE; Liu S; Tu D; Goss PE
J Clin Oncol; 2006 Aug; 24(22):3629-35. PubMed ID: 16822845
[TBL] [Abstract][Full Text] [Related]
9. Effect of chemotherapy and different chemotherapy regimens on bone health among Chinese breast cancer women in different menstrual status: a self-control study.
Peng BQ; Wu J; Tian S; Qu XQ; Liang XY; Feng JH; Chen YL; She RL; Ma CY; Song JY; Li ZX; Jiang ZY; Wu KN; Kong LQ
Support Care Cancer; 2023 Aug; 31(9):540. PubMed ID: 37642751
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait.
Al-Shoumer KA; Nair V
Arch Osteoporos; 2012; 7():147-53. PubMed ID: 23225292
[TBL] [Abstract][Full Text] [Related]
11. Change in bone mineral density during adjuvant chemotherapy for early-stage breast cancer.
Christensen CØ; Cronin-Fenton D; Frøslev T; Hermann AP; Ewertz M
Support Care Cancer; 2016 Oct; 24(10):4229-36. PubMed ID: 27146497
[TBL] [Abstract][Full Text] [Related]
12. Aged-Related Changes in Body Composition and Association between Body Composition with Bone Mass Density by Body Mass Index in Chinese Han Men over 50-year-old.
Jiang Y; Zhang Y; Jin M; Gu Z; Pei Y; Meng P
PLoS One; 2015; 10(6):e0130400. PubMed ID: 26090818
[TBL] [Abstract][Full Text] [Related]
13. The effect of ovarian dysfunction on bone mineral density in breast cancer patients 10 years after adjuvant chemotherapy.
Vehmanen LK; Elomaa I; Blomqvist CP; Saarto T
Acta Oncol; 2014 Jan; 53(1):75-9. PubMed ID: 23713891
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for low bone mineral density and the 6-year rate of bone loss among premenopausal and perimenopausal women.
Bainbridge KE; Sowers M; Lin X; Harlow SD
Osteoporos Int; 2004 Jun; 15(6):439-46. PubMed ID: 15205714
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status.
Vehmanen L; Elomaa I; Blomqvist C; Saarto T
J Clin Oncol; 2006 Feb; 24(4):675-80. PubMed ID: 16446340
[TBL] [Abstract][Full Text] [Related]
16. A Randomized Controlled Trial of Exercise to Prevent Bone Loss in Premenopausal Women with Breast Cancer.
Tabatabai LS; Bloom J; Stewart S; Sellmeyer DE
J Womens Health (Larchmt); 2019 Jan; 28(1):87-92. PubMed ID: 30312118
[TBL] [Abstract][Full Text] [Related]
17. Impact + resistance training improves bone health and body composition in prematurely menopausal breast cancer survivors: a randomized controlled trial.
Winters-Stone KM; Dobek J; Nail LM; Bennett JA; Leo MC; Torgrimson-Ojerio B; Luoh SW; Schwartz A
Osteoporos Int; 2013 May; 24(5):1637-46. PubMed ID: 22996743
[TBL] [Abstract][Full Text] [Related]
18. [Effect of body mass index on bone mass of lumbar spine of male patients with ostealgia and arthralgia but without osteoporosis].
Zhang J; Luo Q; He C; Yang L; He H; Wu Y; Xie W; Xiong E
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Aug; 26(4):852-5, 860. PubMed ID: 19813625
[TBL] [Abstract][Full Text] [Related]
19. Osteoporosis in women with breast cancer and its effect on quality of life: a pilot study.
Turan Y; Kocaaga Z; Karakoyun-Celik O; Gurgan A; Duransoy A
J BUON; 2009; 14(2):239-43. PubMed ID: 19650173
[TBL] [Abstract][Full Text] [Related]
20. Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study.
Coleman RE; Banks LM; Girgis SI; Kilburn LS; Vrdoljak E; Fox J; Cawthorn SJ; Patel A; Snowdon CF; Hall E; Bliss JM; Coombes RC;
Lancet Oncol; 2007 Feb; 8(2):119-27. PubMed ID: 17267326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]